{"transactions":[{"id":4639698,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":83907,"kind":"person","name":"Cole Jeffrey Scott","position":1,"cik":"0001751100","reported_name":"Cole Jeffrey Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2026-10-13T21:32:31.000Z","date":"2026-10-09","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock options have a grant date of October 9, 2026 under the Issuer's 2022 Successor Equity Incentive Plan, were fully vested and immediately exercisable on the date of grant, and have an exercise price equal to the closing price of the Issuer's common stock on October 9, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a grant date of October 9, 2026 under the Issuer's 2022 Successor Equity Incentive Plan, were fully vested and immediately exercisable on the date of grant, and have an exercise price equal to the closing price of the Issuer's common stock on October 9, 2026."}],"balance_after":150000,"derivative":{"exercise_price":0.91,"exercise_date":"2026-10-09","expiration_date":"2036-10-08","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-26-109129","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1937993/000121390026109129/ownership.xml","form_type":"4"}},{"id":1295645,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":83907,"kind":"person","name":"Cole Jeffrey Scott","position":1,"cik":"0001751100","reported_name":"Cole Jeffrey Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options","published_at":"2025-01-24T18:11:37.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of options to purchase 25,000 shares of common stock, which shall vest 1/4 on February 1, 2026 and thereafter pro rata on a monthly basis over three years, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to the fair market value of the Issuer's common stock on the effective date of the grant."}],"balance_after":25000,"derivative":{"exercise_price":19.79,"exercise_date":"2026-02-01","expiration_date":"2035-01-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-25-006635","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751100/000121390025006635/ownership.xml","form_type":"4"}},{"id":1549868,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":83907,"kind":"person","name":"Cole Jeffrey Scott","position":1,"cik":"0001751100","reported_name":"Cole Jeffrey Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options","published_at":"2024-04-03T17:21:23.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of options to purchase 150,000 shares of common stock, which shall vest 1/4 on April 1, 2025 and thereafter pro rata on a monthly basis over three years, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to the fair market value of the Issuer's common stock on the effective date of the grant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Consists of options to purchase 150,000 shares of common stock, which shall vest 1/4 on April 1, 2025 and thereafter pro rata on a monthly basis over three years, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to the fair market value of the Issuer's common stock on the effective date of the grant."}],"balance_after":150000,"derivative":{"exercise_price":0.62,"exercise_date":"2025-04-01","expiration_date":"2034-04-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-24-029930","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751100/000121390024029930/ownership.xml","form_type":"4"}}]}